Nevada
|
000-50340
|
75-2980786
|
||
(State or other jurisdiction
of incorporation)
|
(Commission File Number)
|
(IRS Employer
Identification Number)
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Exhibit No.
|
|
Description
|
99.1
|
|
Press Release issued on May 16, 2011
|
Rodobo International, Inc.
|
||||
By:
|
/s/ Yanbin Wang
|
|||
Name:
|
Yanbin Wang
|
|||
Title:
|
Chairman and Chief Executive Officer
|
|||
l
|
Revenue was $25.6 million, up 67.1% from $15.3 million in 2Q10, close to the upper range of the Company’s 2Q11 guidance $23 - $26 million
|
l
|
Gross profit was $9.7 million, up 62.1% from $6.0 million in 2Q10
|
l
|
Net income was $3.8 million, up 77.0% from non-GAAP net income of $2.2 million in 2Q10, outperforming 2Q11 guidance range of $3.3 - $3.6 million
|
l
|
Earnings per diluted share was $0.14, up from non-GAAP earnings per share of $0.10 in 2Q10
|
March 31,
|
September 30,
|
|||||||
2011
|
2010
|
|||||||
ASSETS
|
||||||||
Current assets:
|
||||||||
Cash and cash equivalents
|
$
|
5,540,856
|
$
|
5,163,789
|
||||
Accounts receivable, net
|
8,437,636
|
8,085,248
|
||||||
Inventories
|
3,169,944
|
1,523,422
|
||||||
Prepaid expenses
|
462,898
|
114,215
|
||||||
Advances to suppliers
|
690,001
|
969,369
|
||||||
Total current assets
|
18,301,335
|
15,856,043
|
||||||
Property, plant and equipment:
|
||||||||
Fixed assets, net of accumulated depreciation
|
22,330,472
|
19,575,890
|
||||||
Construction in progress
|
26,449,165
|
22,701,594
|
||||||
Total property, plant and equipment, net
|
48,779,637
|
42,277,484
|
||||||
Biological assets, net
|
5,233,739
|
3,295,508
|
||||||
Other assets:
|
||||||||
Deposits on land
|
76,352
|
74,726
|
||||||
Intangible assets, net
|
9,664,585
|
10,440,131
|
||||||
Total other assets
|
9,740,937
|
10,514,857
|
||||||
Total Assets
|
$
|
82,055,648
|
$
|
71,943,892
|
||||
LIABILITIES AND STOCKHOLDERS' EQUITY
|
||||||||
Current liabilities:
|
||||||||
Short-term loans
|
$
|
1,717,924
|
$
|
1,218,025
|
||||
Accounts payable
|
2,856,381
|
1,457,624
|
||||||
Other payable
|
141,905
|
723,015
|
||||||
Accrued expenses
|
434,183
|
588,011
|
||||||
Advance from customers
|
30,541
|
-
|
||||||
Due to related parties
|
1,185,062
|
1,491,616
|
||||||
Total current liabilities
|
6,365,996
|
5,478,291
|
||||||
Warrant liability
|
638,176
|
1,414,316
|
||||||
Series A preferred stock, $0.0001 par value, 30,000,000 shares authorized, 2,000,000
|
||||||||
shares issued and outstanding as of March 31, 2011 and September 30, 2010
|
4,100,000
|
4,100,000
|
||||||
Stockholders' equity
|
||||||||
Common stock, $0.0001 par value, 200,000,000 shares authorized, 28,008,600 and 28,003,726 shares
|
||||||||
issued and outstanding as of March 31, 2011 and September 30, 2010, respectively
|
2,801
|
2,800
|
||||||
Additional paid in capital
|
30,941,948
|
30,344,724
|
||||||
Additional paid in capital - warrants
|
971,788
|
971,788
|
||||||
Subscription receivable
|
(50,000
|
)
|
(50,000
|
)
|
||||
Retained earnings
|
35,514,538
|
27,588,952
|
||||||
Accumulated other comprehensive income
|
3,570,401
|
2,093,022
|
For The Three Months Ended
March 31,
|
For The Six Months Ended
March 31,
|
|||||||||||||||
2011
|
2010
|
2011
|
2010
|
|||||||||||||
Net sales
|
$
|
25,623,364
|
$
|
15,330,579
|
$
|
51,209,824
|
$
|
25,406,025
|
||||||||
Cost of goods sold
|
15,885,295
|
9,324,276
|
31,685,522
|
14,104,575
|
||||||||||||
Gross profit
|
9,738,069
|
6,006,303
|
19,524,302
|
11,301,450
|
||||||||||||
Operating expenses:
|
||||||||||||||||
Distribution expenses
|
5,215,578
|
2,846,944
|
10,513,189
|
5,433,116
|
||||||||||||
General and administrative expenses
|
886,280
|
980,105
|
1,718,598
|
1,702,986
|
||||||||||||
Total operating expenses
|
6,101,859
|
3,827,049
|
12,231,787
|
7,136,102
|
||||||||||||
Operating income
|
3,636,210
|
2,179,254
|
7,292,515
|
4,165,348
|
||||||||||||
Subsidy income
|
-
|
-
|
-
|
273,897
|
||||||||||||
Gain on bargain purchase
|
-
|
1,677,020
|
-
|
1,677,020
|
||||||||||||
Interest expenses
|
(53,415
|
)
|
(25,563
|
)
|
(215,838
|
)
|
(25,563
|
)
|
||||||||
Change in fair value of warrants
|
258,023
|
-
|
776,140
|
-
|
||||||||||||
Other income
|
7,601
|
20,499
|
72,769
|
22,889
|
||||||||||||
Income before income taxes
|
3,848,419
|
3,851,210
|
7,925,586
|
6,113,591
|
||||||||||||
Provision for income taxes
|
-
|
-
|
-
|
-
|
||||||||||||
Net income
|
$
|
3,848,419
|
$
|
3,851,210
|
$
|
7,925,586
|
$
|
6,113,591
|
||||||||
Other comprehensive income:
|
||||||||||||||||
Foreign currency translation adjustment
|
583,631
|
9,230
|
1,477,379
|
7,046
|
||||||||||||
Comprehensive income
|
$
|
4,432,051
|
$
|
3,860,440
|
$
|
9,402,965
|
$
|
6,120,637
|
||||||||
Earnings per share
|
||||||||||||||||
Basic
|
$
|
0.14
|
$
|
0.18
|
$
|
0.29
|
$
|
0.34
|
||||||||
Diluted
|
$
|
0.14
|
$
|
0.18
|
$
|
0.29
|
$
|
0.32
|
||||||||
Weighted average shares outstanding
|
||||||||||||||||
Basic
|
27,331,855
|
21,043,725
|
27,331,116
|
18,096,169
|
||||||||||||
Diluted
|
27,845,391
|
21,731,834
|
27,795,225
|
18,907,912
|
For The Three Months Ended
March 31,
|
For The Six Months Ended
March 31,
|
|||||||||||||||
2011
|
2010
|
2011
|
2010
|
|||||||||||||
Net sales
|
$
|
25,623,364
|
$
|
15,330,579
|
$
|
51,209,824
|
$
|
25,406,025
|
||||||||
Cost of goods sold
|
15,885,295
|
9,324,276
|
31,685,522
|
14,104,575
|
||||||||||||
Gross profit
|
9,738,069
|
6,006,303
|
19,524,302
|
11,301,450
|
||||||||||||
Operating expenses:
|
||||||||||||||||
Distribution expenses
|
5,215,578
|
2,846,944
|
10,513,189
|
5,433,116
|
||||||||||||
General and administrative expenses
|
886,280
|
980,105
|
1,718,598
|
1,702,986
|
||||||||||||
Total operating expenses
|
6,101,859
|
3,827,049
|
12,231,787
|
7,136,102
|
||||||||||||
Operating income
|
3,636,210
|
2,179,254
|
7,292,515
|
4,165,348
|
||||||||||||
Subsidy income
|
-
|
-
|
-
|
273,897
|
||||||||||||
Interest expenses
|
(53,415
|
)
|
(25,563
|
)
|
(215,838
|
)
|
(25,563
|
)
|
||||||||
Change in fair value of warrants
|
258,023
|
-
|
776,140
|
-
|
||||||||||||
Other income
|
7,601
|
20,499
|
72,769
|
22,889
|
||||||||||||
Income before income taxes
|
3,848,419
|
2,174,190
|
7,925,586
|
4,436,571
|
||||||||||||
Provision for income taxes
|
-
|
-
|
-
|
-
|
||||||||||||
Net income
|
$
|
3,848,419
|
$
|
2,174,190
|
$
|
7,925,586
|
$
|
4,436,571
|
||||||||
Other comprehensive income:
|
||||||||||||||||
Foreign currency translation adjustment
|
583,631
|
9,230
|
1,477,379
|
7,046
|
||||||||||||
Comprehensive income
|
$
|
4,432,051
|
$
|
2,183,420
|
$
|
9,402,965
|
$
|
4,443,617
|
||||||||
Earnings per share
|
||||||||||||||||
Basic
|
$
|
0.14
|
$
|
0.10
|
$
|
0.29
|
$
|
0.25
|
||||||||
Diluted
|
$
|
0.14
|
$
|
0.10
|
$
|
0.29
|
$
|
0.23
|
||||||||
Weighted average shares outstanding
|
||||||||||||||||
Basic
|
27,331,855
|
21,043,725
|
27,331,116
|
18,096,169
|
||||||||||||
Diluted
|
27,845,391
|
21,731,834
|
27,795,225
|
18,907,912
|
|
For The Six Months Ended March 31,
|
|||||||
2011
|
2010
|
|||||||
Cash flows from operating activities
|
||||||||
Net income
|
$
|
7,925,586
|
$
|
6,113,591
|
||||
Adjustments to reconcile net income to net cash provided by operating activities
|
||||||||
Depreciation and amortization
|
1,769,927
|
1,215,529
|
||||||
Stock-based compensation
|
597,226
|
696,809
|
||||||
Gain on bargain purchase
|
-
|
(1,677,020
|
)
|
|||||
Change in fair value of warrants
|
(776,140
|
)
|
-
|
|||||
Changes in assets and liabilities:
|
||||||||
(Increase) decrease in -
|
||||||||
Accounts receivable, net
|
(128,933
|
)
|
(2,664,291
|
)
|
||||
Inventories
|
(1,594,252
|
)
|
742,046
|
|||||
Prepaid expenses
|
(397,275
|
)
|
(26,289
|
)
|
||||
Advances to suppliers
|
297,313
|
1,500,731
|
||||||
Increase (decrease) in -
|
||||||||
Accounts payable and other payable
|
724,228
|
1,504,910
|
||||||
Accrued expenses
|
(110,961
|
)
|
(500,152
|
)
|
||||
Advance from customers
|
30,220
|
(570,447
|
)
|
|||||
Net cash provided by operating activities
|
8,336,939
|
6,335,417
|
||||||
Cash flows from investing activities
|
||||||||
Purchase of fixed assets
|
(352,318
|
)
|
(394,212
|
)
|
||||
Cash used for construction in progress
|
(5,833,198
|
)
|
(2,614,419
|
)
|
||||
Purchase of mature biological assets
|
(2,058,757
|
)
|
-
|
|||||
Cash acquired in acquisitions, net of cash paid
|
-
|
1,055,994
|
||||||
Collection of loan to others
|
-
|
732,300
|
||||||
Collection of loan to shareholders
|
-
|
923,627
|
||||||
Net cash used in investing activities
|
(8,244,274
|
)
|
(296,710
|
)
|
||||
Cash flows from financing activities
|
||||||||
Proceeds from short-term loans
|
1,133,247
|
549,237
|
||||||
Repayment of short-term loans
|
(664,838
|
)
|
-
|
|||||
Repayment of related party loans
|
(309,935
|
)
|
(1,933,667
|
)
|
||||
Net cash provided by (used in) financing activities
|
158,474
|
(1,384,430
|
)
|
|||||
Effect of exchange rate changes on cash and cash equivalents
|
125,927
|
1,226
|
||||||
Net increase in cash and cash equivalents
|
377,066
|
4,655,502
|
||||||
Cash and cash equivalents, beginning of period
|
5,163,790
|
1,640,259
|
||||||
Cash and cash equivalents, end of period
|
$
|
5,540,856
|
$
|
6,295,761
|
||||
Supplemental disclosures of cash flow information:
|
||||||||
Interest paid
|
$
|
14,669
|
$
|
30,297
|
||||
Income taxes paid
|
$
|
-
|
$
|
-
|
||||
Non-cash investing and financing activities:
|
||||||||
Common stock issued for services
|
$
|
11,893
|
$
|
225,876
|
||||
Common stock issued for business acquisition
|
$
|
-
|
$
|
23,850,000
|
||||
Preferred stock issued for business acquisition
|
$
|
-
|
$
|
4,100,000
|
K#JI74:\?J.'DM@'D\)2./Z5]VBWW*Z]069K%K
MF]I=S#RLLJ_VT]W)W'&!@9_I4QZB]-=03-82KG966Y4>2X'0>ZE!;5Z@A1&>
M1Z4$3Y(W%C;\WRI?J8H=1'Q7@'81D];'PH1UFRO7MU1R2CLH2,^S:!7CUR;/
M\6_#`@J;M\=K/H3VQS_>K'@=-[G